Comparison of Risk Stratification Tools in Predicting Outcomes of Patients With Higher-Risk Myelodysplastic Syndromes Treated With Azanucleosides
Leukemia - United Kingdom
doi 10.1038/leu.2015.283
Full Text
Open PDFAbstract
Available in full text
Date
October 14, 2015
Authors
Publisher
Springer Science and Business Media LLC